PRKN and breast cancer: The inhibition of mitophagy by DRP1 shRNA or Parkin shRNA promoted flubendazole-inhibited cell viability and colony formation of MDA-MB-231 and MCF-7 cells, indicating that flubendazole suppresses breast cancer cell proliferation via promoting mitophagy.